Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay

NCT02586389 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2024-10-16

No results posted yet for this study

Summary

This specimen collection is designed to obtain whole blood and tumor tissue from subjects diagnosed with cancer for the purpose of the development of a noninvasive liquid biopsy assay using next generation sequencing (NGS).

Conditions

  • Non-hematologic Cancer

Sponsors & Collaborators

  • Sequenom, Inc.

    lead INDUSTRY

Principal Investigators

  • Sue Beruti, MD · Sequenom, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-13
Primary Completion
2027-10-31
Completion
2027-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02586389 on ClinicalTrials.gov